Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America

作者: Oscar Arrieta , Andrés Felipe Cardona , Guillermo Federico Bramuglia , Aly Gallo , Alma D Campos-Parra

DOI: 10.1097/JTO.0B013E31822F655F

关键词:

摘要: Introduction Frequency of mutations in EGFR and KRAS non-small cell lung cancer (NSCLC) is different between ethnic groups; however, there no information Latin-American population. Methods A total 1150 biopsies NSCLC patients from Latin America (Argentina, Colombia, Peru, Mexico) were used extracting genomic DNA to perform direct sequencing gene (exons 18 21) 650 samples. In Mexico, Scorpions ARMS was also obtain a genetic profile. Results We report the frequency genes four countries ( n = 1150). 33.2% (95% confidence interval [CI] 30.5–35.9) (Argentina 19.3%, Colombia 24.8%, Mexico 31.2%, Peru 67%). The 16.6% CI 13.8–19.4). independently associated with adenocarcinoma histology, older age, nonsmokers, absence mutations. Overall response rate tyrosine kinase inhibitors EGFR-mutated 56) 62.5% 50–75) median overall survival 16.5 months 12.4–20.6). Conclusions Our findings suggest that lies Asian Caucasian populations therefore support heterogeneity around world.

参考文章(16)
Nancy E. Hynes, Heidi A. Lane, ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews Cancer. ,vol. 5, pp. 341- 354 ,(2005) , 10.1038/NRC1609
Gregory J. Riely, Mark G. Kris, Daniel Rosenbaum, Jenifer Marks, Allan Li, Dhananjay A. Chitale, Khedoudja Nafa, Elyn R. Riedel, Meier Hsu, William Pao, Vincent A. Miller, Marc Ladanyi, Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clinical Cancer Research. ,vol. 14, pp. 5731- 5734 ,(2008) , 10.1158/1078-0432.CCR-08-0646
Kenichi Suda, Kenji Tomizawa, Tetsuya Mitsudomi, Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. Cancer and Metastasis Reviews. ,vol. 29, pp. 49- 60 ,(2010) , 10.1007/S10555-010-9209-4
Rom S. Leidner, Pingfu Fu, Bradley Clifford, Ayad Hamdan, Cheng Jin, Rosana Eisenberg, Titus J. Boggon, Margaret Skokan, Wilbur A. Franklin, Federico Cappuzzo, Fred R. Hirsch, Marileila Varella-Garcia, Balazs Halmos, Genetic Abnormalities of the EGFR Pathway in African American Patients With Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 27, pp. 5620- 5626 ,(2009) , 10.1200/JCO.2009.23.1431
Oscar Arrieta, Luis Martinez-Barrera, Sergio Trevino, Enrique Guzman, Patricia Castillo-Gonzalez, Miguel Angel Rios-Trejo, Diana Flores-Estrada, Eduardo Téllez, Cesar Gonzalez, Johny de la Cruz Vargas, Claudia Haydee Gonzalez-De la Rosa, Norma Hernandez-Pedro, Rafael Morales-Barrera, Jaime De la Garza, None, Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-treated Non-small Cell Lung Cancer Patients: An Open Label Phase II Study Journal of Thoracic Oncology. ,vol. 3, pp. 887- 893 ,(2008) , 10.1097/JTO.0B013E31818026F6
Michele L. Cote, Ramsi Haddad, David J. Edwards, Govindaraja Atikukke, Shirish Gadgeel, Ayman O. Soubani, Fulvio Lonardo, Gerold Bepler, Ann G. Schwartz, Stephen P. Ethier, Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans with Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 6, pp. 627- 630 ,(2011) , 10.1097/JTO.0B013E31820A0EC0
Yoon Hee Choi, Jin Kyung Lee, Hye Jin Kang, Tae Sup Lee, Hye-Ryoun Kim, Cheol Hyeon Kim, Jae Soo Koh, Hee Jong Baek, Jae Cheol Lee, Im Il Na, Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 5, pp. 1949- 1952 ,(2010) , 10.1097/JTO.0B013E3181F38816
Rafael Rosell, Teresa Moran, Cristina Queralt, Rut Porta, Felipe Cardenal, Carlos Camps, Margarita Majem, Guillermo Lopez-Vivanco, Dolores Isla, Mariano Provencio, Amelia Insa, Bartomeu Massuti, Jose Luis Gonzalez-Larriba, Luis Paz-Ares, Isabel Bover, Rosario Garcia-Campelo, Miguel Angel Moreno, Silvia Catot, Christian Rolfo, Noemi Reguart, Ramon Palmero, José Miguel Sánchez, Roman Bastus, Clara Mayo, Jordi Bertran-Alamillo, Miguel Angel Molina, Jose Javier Sanchez, Miquel Taron, None, Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer The New England Journal of Medicine. ,vol. 361, pp. 958- 967 ,(2009) , 10.1056/NEJMOA0904554
Elizabeth T. H. Fontham, Monica Haddican, Brian G. Luckett, Wayne L. Backes, T. William Axelrad, Bernardo Ruiz, Anna Strimas, Marilyn Eyer, Jay D. Hunt, Julie E. Martin, Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 11, pp. 1405- 1412 ,(2002)
William Pao, Theresa Y Wang, Gregory J Riely, Vincent A Miller, Qiulu Pan, Marc Ladanyi, Maureen F Zakowski, Robert T Heelan, Mark G Kris, Harold E Varmus, KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib PLOS Medicine. ,vol. 2, ,(2005) , 10.1371/JOURNAL.PMED.0020017